登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Carbonic Anhydrase IX】

Carbonic Anhydrase IX信息

英文名称:Carbonic anhydrase IX
中文名称:碳酸酐酶IX
靶点别称:EC:4.2.1.1,Renal cell carcinoma-associated antigen G250,P54/58N,CA9,Carbonic Anhydrase 9,RCC-Associated Protein G250,Carbonate Dehydratase IX,Carbonic Dehydratase,CA-IX,CAIX,PMW1,MN,EC 4.2.1.1,G250,Carbonic anhydrase IX,Membrane antigen MN,RCC-associated antigen G250
上市药物数量:0
临床药物数量:10
最高研发阶段:临床三期

Carbonic Anhydrase IX产品列表

ACRO质量管理体系
 
评论(4)
CA9-H5253|Human Carbonic Anhydrase IX / CA9 (38-414) Protein, Fc Tag (MALS verified)
  1. 173XXXXXXX1
  2. 4人赞
  3. 蛋白用来做药物筛选,纳米抗体。我们课题组都购买的acro产品,质量不错,比较稳定。我们一直在用,不过产品种类不多。有待覆盖更多类型产品。
  4. 2022-01-07
CA9-H5220|Human Carbonic Anhydrase IX / CA9 (138-414) Protein, His Tag (MALS verified)
  1. 139XXXXXXX3
  2. 4人赞
  3. 到货速度很快,抗原包装完好,溶解方法描述清晰,溶解方法简单,溶解度很好,进行实验非常顺利,质量有保障,买了很多次,质量始终如一
  4. 2022-01-05
CA9-H5253|Human Carbonic Anhydrase IX / CA9 (38-414) Protein, Fc Tag (MALS verified)
  1. 139XXXXXXX3
  2. 4人赞
  3. 用于抗体筛选的监测工作,目前方法建立顺利进行中,提供的技术支持也比较完善,试验中出现的问题都能给予多方面的支持
  4. 2021-07-13
 

Carbonic Anhydrase IX分子别名

CAIX,CA9,CA-IX,G250,MN,P54,58N,pMW1

Carbonic Anhydrase IX分子背景

Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes. CAs form a family of enzymes that catalyze the rapid interconversion of carbon dioxide and water to bicarbonate and protons (or vice versa), a reversible reaction that occurs rather slowly in the absence of a catalyst. One of the functions of the enzyme in animals is to interconvert carbon dioxide and bicarbonate to maintain acid-base balance in blood and other tissues, and to help transport carbon dioxide out of tissues. The active site of most carbonic anhydrases contains a zinc ion. There are at least five distinct CA families (α, β, γ, δ and ε).
Carbonic anhydrase 9 (CA9 / CAIX) is also known as Membrane antigen MN (MN), Renal cell carcinoma-associated antigen G250, which belongs to the alpha-carbonic anhydrase family. CA9 / CAIX with an optimal activity at pH 6.49. Reversible hydration of carbon dioxide. CA IX participates in pH regulation. CA9 may be involved in the control of cell proliferation and transformation. CA-IX appears to be a novel specific biomarker for a cervical neoplasia.

Carbonic Anhydrase IX临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
Girentuximab-Zr-89 TLX-250-CDx; 89Zr-TX-250; TLX250-CDx; 89Zr-TX250 临床三期 膀胱癌, 肝细胞癌, 宫颈癌, 非小细胞肺癌, 胰腺导管癌, 结直肠癌, 鼻咽癌, 肉瘤, 胆管上皮癌, 造影检查, 实体瘤, 尿路上皮癌, 卵巢上皮癌, 胶质母细胞瘤, 三阴性乳腺癌, 小细胞肺癌, 肾细胞癌, 头颈部鳞状细胞癌, 食道癌, 胃癌 详情
Lutetium-177 DOTA girentuximab TLX-250 临床二期 Heidelberg, Telix Pharmaceuticals Ltd 实体瘤, 肾细胞癌, 肿瘤 详情
[177Lu]Lu-DPI-4452 [177Lu]Lu-DPI-4452 临床二期 Debiopharm International Sa 肾细胞癌, 结直肠癌, 胰腺导管癌 详情
Debio-0328 [68Ga]Ga-DPI-4452; Gallium-68-DPI-4452 临床二期 Debiopharm International Sa 肾细胞癌, 结直肠癌, 胰腺导管癌 详情
PMI-05 PMI-05 临床一期 Precision Molecular Inc 肿瘤 详情
Girentuximab  MAb-G250; cG250; WX-G250 临床一期 肾肿瘤, 肾细胞癌 详情
PHC-102 PHC102; 99mTc-CAIX 临床一期 Philochem 肾细胞癌 详情
Indium-111-DOTA-girentuximab-IRDye800CW (Radboud University) 临床一期 Radboud University Nijmegen 肾细胞癌, 诊断剂 详情
CA9hu-1 CA9hu-1 临床一期 Mabpro AS 头颈癌, 肾细胞癌, 三阴性乳腺癌, 间皮组织肿瘤, 非小细胞肺癌 详情
Sulfamide-nitroimidazole 临床阶段不明 Dualtpharma 肿瘤 详情

消息提示

请输入您的联系方式,再点击提交!

确定